Generation of glial cell diversity in the developing spinal cord is known to depend on spatio-temporal patterning programs. In particular, expression of the transcription factor Olig2 in neural progenitors of the pMN domain is recognized as critical to their fate choice decision to form oligodendrocyte precursor cells (OPCs) instead of astrocyte precursors (APs). However, generating some confusion, lineage-tracing studies of Olig2 progenitors in the spinal cord provided evidence that these progenitors also generate some astrocytes. Here, we addressed the role of the heparan sulfate-editing enzyme Sulf2 in the control of gliogenesis and found an unanticipated function for this enzyme. At initiation of gliogenesis in mouse, Sulf2 is expressed in ventral neural progenitors of the embryonic spinal cord, including in Olig2-expressing cells of the pMN domain. We found that sulf2 deletion, while not affecting OPC production, impairs generation of a previously unknown Olig2-expressing pMN-derived cell subtype that, in contrast to OPCs, does not upregulate Sox10, PDGFRα or Olig1.
. Under the influence of patterning signals, progenitor cells of the ventral neural tube activate or repress sets of transcription factors that subsequently subdivide this structure into distinct progenitor domains, each dedicated to first generate specific neuronal subtypes, followed by glial cells (Ben Haim & Rowitch, 2017) . Among them, the pMN domain, populated by progenitor cells expressing the transcription factor Olig2, first generates all motor neurons (MNs) and change with time to produce most oligodendrocyte precursor cells (OPCs) of the spinal cord. Meanwhile, the ventrally and dorsally located p1 to p3 domains initially produce V1 to V3 interneurons and then change their fate to generate three distinct ventral astrocyte precursor cell (AP) subtypes (VA1-3). Thus, the origins of OPCs and APs are considered to be more closely connected to neuron subtype progenitor cells than with each other. The mechanistic parallel between neuron and glial cell development is well exemplified by functional analysis of the transcription factor Olig2, expressed in pMN cells.
In Olig2 null spinal cords, pMN cells fail to generate both MNs and OPCs (Lu et al., 2002; Takebayashi, Nabeshima, Yoshida, Chisaka, & Ikenaka, 2002; Zhou & Anderson, 2002) . Instead, in these mutants, supernumerary V2 interneurons and APs are produced as a consequence of transformation of the presumptive pMN domain into a p2 domain. Therefore, spinal OPCs and APs have been proposed to develop along mutually exclusive paths, Olig2 being viewed as a repressor of a "pro-astrocytic" program (Rowitch & Kriegstein, 2010) . Olig2 is also considered as a key determinant of OPC specification, maturation, and differentiation and it continues to be present in differentiated oligodendrocytes of the adult spinal cord (Meijer et al., 2012) . However, contrasting with the notion that Olig2 represses the astrocytic fate, lineage-tracing studies brought evidence that Olig2-expressing progenitors of the pMN domain generate some astrocytes (Masahira et al., 2006; Tsai et al., 2012) .
Beyond spatial control, a temporal component is important to initiate gliogenesis. Although timing mechanism regulating AP commitment remains elusive, OPC commitment from pMN cells is known to rely on a temporal rise of sonic hedgehog (Shh) signaling activity (Danesin & Soula, 2017) . The heparan sulfate-editing enzyme Sulf1, known to modulate the sulfation state of heparan sulfate proteoglycans (HSPGs) at the cell surface (Lamanna et al., 2007) , is a key player in this process. This enzyme is expressed specifically by Shh-secreting cells of the floor plate immediately prior to OPC specification. Sulf1, by eliminating 6O sulfate groups on HS chains, locally lowers Shh/HSPG interaction and thereby promotes Shh release at the right time to trigger OPC specification from Olig2-expressing pMN cells (Al Oustah et al., 2014; Touahri et al., 2012) . Jiang et al. (2017) more recently reported that Sulf2, the second member of the Sulf protein family (El Masri, Seffouh, Lortat-Jacob, & Vivès, 2017) , plays a similar role as Sulf1 in triggering the MN to OPC fate change. In the present work, we also investigated the function of Sulf2 in the control of gliogenesis during spinal cord development and came to the different conclusion that Sulf2 is dispensable for OPC production. Instead, we found that Sulf2, which in contrast to Sulf1 is expressed in pMN cells, promotes generation of APs.
Furthermore, we showed that APs generated under the influence of Sulf2 are distinguishable from other APs by the expression of Olig2 from initial stages of their generation in the ventral spinal cord to their final maturation at postnatal stages. These results therefore reveal a previously uncharacterized spinal cord AP subtype characterized by expression of Olig2. By highlighting the role of Sulf2 in this glial subtype development, our data also reveal distinct developmental mechanisms for generation of OPC and AP from progenitor cells of the pMN domain.
| MATERIALS AND METHODS

| Mouse strains
All procedures were performed in agreement with the European Community guiding principles on the care and use of animals (Scientific Procedures) Act, 1987 and approved by the national Animal Care and Ethics Committee (APAFIS#01331.02) following Directive 2010/63/ EU. Sulf2 mutant and floxed mice have been generated by Ai et al. (2007) . Sulf2 mutant carry deletion of the second coding exon (exon 2) of sulf2, which encodes essential amino acids in the enzymatic domain of the protein (Dhoot et al., 2001 ). Sulf2 floxed mice carry LoxP sites flanking the exon2 of sulf2. Sulf2 mutant and floxed mice were genotyped as previously reported (Ai et al., 2007; Tran, Shi, Zaia, & Ai, 2012) . Parental olig2-cre +/− ;sulf2 fl/+ ;R26R-tomato mice were generated by crossing heterozygous knock-in olig2-cre line (Dessaud et al., 2007) by genotyping. GFAP-GFP and Aldh1L1-GFP transgenic mice were genotyped as previously reported (Gong et al., 2003; Heintz, 2004; Nolte et al., 2001) . Parental sulf2 +/− ; Aldh1L1-GFP mice were generated by crossing heterozygous sulf2 mutant mouse to an Aldh1L1-GFP transgenic mouse. Then, sulf2 +/− ; Aldh1L1-GFP mice were crossed and sulf2 +/+ ; Aldh1L1-GFP and sulf2 −/− ; Aldh1L1-GFP littermate embryos were selected by genotyping. All mice were maintained on a C57BL/6 background.
| Thymidine analogue labeling
For proliferation assays, the timed pups (P0) were injected intraperitoneally with 5-ethylyl-2-deoxyuridine (EdU, Invitrogen) at 50 μg/g body weight once a day from postnatal Day 0 to postnatal Day 2. The animals were then sacrificed 2 hr after the last injection. EdU incorporation was detected using the AlexaFluor-647 Click-iT Imaging Kit (Invitrogen).
| Tissue processing
Spinal cords at the brachial level were isolated from E12.5 to E18.5 mouse embryos and fixed in 4% paraformaldehyde (PFA, Sigma) in phosphate-buffered saline (PBS) overnight at 4 C. Adult mice were perfused intracardially with 4% PFA (Sigma) in PBS. Adult spinal cords were dissected and postfixed in 4% PFA in PBS overnight at 4 C.
Tissues were then sectioned either at 60-80 μm using a vibratome (Microm) or at 15 to 25 μm using a cryostat (Leica CM1950) after cryoprotection in 20% sucrose (Sigma) in PBS and freezing in OCT media on the surface of dry ice.
| In situ RNA hybridization and immunofluorescent staining
Simple or double in situ hybridization and immunofluorescent staining were performed on transverse sections as previously reported (Touahri et al., 2012; Ventéo et al., 2012) . Digoxigenin-or Fluorescein-labeled antisens RNA probes for sulf2, aldh1L1, fgfr3, sox10, and tenascin-C were synthesized using DIG-or Fluorescein-labelling kit (Roche) according to the manufacturer's instructions and revealed using either parenchymal OPCs have been generated at E12.5 in sulf2−/− and wild-type embryos (Figure 1e ,f). Therefore, contrasting with previous study (Jiang et al., 2017) , our data indicated that Sulf2 is dispensable for initiation of OPC production in the ventral spinal cord. To get further insight on this disparity of results, we next considered the possibility that Sulf2 might impair ongoing OPC production at later developmental stages. We then examined Olig2 and Sox10 expression 1 day later, at E13.5, and, again, found similar patterns of Olig2/ Sox10 coexpression in sulf2−/− and wild-type littermate embryos ( Figure 1g -h 00 ,k). We therefore concluded that Sulf2 activity is not required to sustain OPC generation. However, we made at that stage a quite unexpected observation. We found that, in wild-type embryos, while coexpression of Olig2 and Sox10 was detected in most cells streaming away from the pMN domain, expression of Sox10 remained undetectable in a subset of parenchymal Olig2+ cells ( Figure 1g -g 000 , i-i 00 ).
These Olig2+/Sox10 _ cells were predominantly found close to the progenitor zone, suggesting that they had been recently generated. In sup- Olig2+ cells that do not activate Sox10 while populating the spinal parenchyma.
We next asked whether Sulf2 expression specifically in Olig2+ cells is required for proper generation of the Olig2+/Sox10 _ cell subtype. To test this, we turned to a mouse line that carries a "floxed" allele of sulf2 (Tran et al., 2012) . By breeding sulf2 "floxed" mice with olig2 promoter-driven Cre (Olig2-cre) knock-in mice (Dessaud et and specific hallmarks of OPCs in the spinal cord (Meijer et al., 2012; Pringle & Richardson, 1993) . We then investigated the possibility that Olig2+/Sox10 _ cells might be related to the astroglial lineage. For this, we combined immunodetection of Olig2 and in situ localization of fgfr3, aldh1L1, and tenascin-C mRNAs, all reported to mark spinal APs as well as progenitors from which they originate (Cahoy et al., 2008; Karus, Denecke, ffrench-Constant, Wiese, & Faissner, 2011; Pringle et al., 2003) . At E13.5, fgfr3 mRNA was or tenascin-C mRNAs and the Olig2 protein (Figure 3g ,h). These data therefore revealed the existence of a ventral spinal cord AP subtype that distinguishes itself from others by Olig2 expression.
Due to the setback of combining Sox10 immunostaining with in situ hybridization, we were not able to directly define whether fgfr3+/Olig2+ APs match the Olig2+/Sox10 _ cell population. We therefore turned to Aldh1L1-GFP astrocyte-specific reporter mice (Cahoy et al., 2008) To learn more about the Olig2+ AP subtype, we next performed immunostaining using antibodies specific for Nkx6.1, expressed in APs originating from ventral progenitors, and for NFIA and Zeb1, two transcription factors broadly expressed in newly generated spinal APs (Deneen et al., 2006; Ohayon et al., 2016; Zhao et al., 2014) . We found that essentially all Olig2+/Sox10 _ cells coexpress these proteins at E14.5 (Figure 5 ), indicating that they share the same basic properties as previously identified ventral APs.
Together, these data reveal the existence of a spinal AP subtype that emerge from Olig2-expressing progenitor cells and maintain Olig2 expression as they populate the ventral spinal parenchyma. For convenience, we refer to this sub-population henceforth as Olig2+ APs.
3.3 | Olig2+ APs maintain expression of Olig2 while activating astrocyte differentiation genes
We next examined whether, as previously reported for cortical white matter APs (Cai et al., 2007; Marshall, Novitch, & Goldman, 2005) , expression of Olig2 in ventral spinal cord APs reflects an immature stage of astrocytogenesis. Specific markers for different stages of AP maturation are not available. However, acquisition of mature astrocyte identity in the spinal cord can be followed according to the previously reported stepwise process of their maturation (Tien et al., 2012 3.4 | Sulf2 depletion while impairing the first wave of AP production does not cause major spinal cord AP deficit 
| DISCUSSION
Astrocytes are currently considered to be a remarkably heterogeneous population of cells exhibiting highly diverse functional properties that can impact their influence on neuronal transmission. However, although functional heterogeneity of astrocytes is a well-established concept, how this diversity is generated still remains elusive. In particular, the question remains whether patterning transcription factors contribute to generate stable molecular and functional diversity in astrocytes, as they do in neurons. In the present work, by addressing the role of Sulf2 in the mouse embryonic spinal cord, we highlight a specific function for this enzyme in controlling production of a specific AP subtype, which, remarkably, expresses Olig2 at all stages of its development. We therefore characterized astrocytes displaying an "Olig2 identity" from initial stage of their generation to terminal differentiation in the ventral spinal cord and identified a specific player of their generation.
Our work reveals a previously undefined heterogeneity within the population of Olig2+ glial precursor cells generated in the early gliogenic spinal cord. So far, although pMN cells are recognized to generate some astroglial cells (Masahira et al., 2006; Tsai et al., 2012) , the nature of their precursor cells in the spinal cord parenchyma was unknown. Thus, OPCs were the only pMN-derived glial precursor cells to have been characterized. Typical OPC molecular identity relies on expression of Olig2 together with Sox10, Olig1, and PDGFRα, a set of genes activated as soon as pMN cells commit to the OPC fate (Bergles & Richardson, 2015 (Liu & Rao, 2004) . However, their existence in vivo has been the subject of debate (Rowitch & Kriegstein, 2010) . A previous study by Jiang and collaborators (Jiang et al., 2017) reported that Sulf2 depletion caused deficient production of OPCs at the initial stage of gliogenesis, that is, E12.5. Here we show that lack of Sulf2 leads to defective Olig2+ AP generation but has no effect on OPC generation during all development, from E12.5 to E18.5. At first, differences in mouse models and/or markers used to identify OPCs could possibly account for these differences. However, both mouse lines from Nagamine and collaborators (Nagamine et al., 2012) in the study of Jiang and collaborators and from Ai and collaborators (Ai et al., 2007) in the present study, should be functionally similar inasmuch as they carry deletions in the region encoding the catalytic site of the enzyme. Also, cells expressing PDGFRα (as in the study of Jiang et al., 2017) or Olig2/Sox10 (as in our present work) are recognized as a single cell population in the embryonic ventral spinal cord (Finzsch, Stolt, Lommes, & Wegner, 2008; Zhou et al., 2000) . Therefore, there is currently no evident explanation for this discrepancy.
Nevertheless, the effect of the lack of Sulf2 on Olig2+ AP generation highlights the important role of Sulf2 in glial subtype development. have been reported to populate the thalamus (Griemsmann et al., 2015) , indicating that Olig2 expression is also maintained in at least subtypes of astrocytes of the adult brain. Therefore, our work, by uncovering production of Olig2+ APs at initial stages of gliogenesis, sheds light on the developmental origin of spinal cord Olig2+ astrocytes. The most striking aspect is that ventral spinal Olig2+ APs maintain expression of Olig2 as they acquire a mature astrocytic identity. It is therefore obvious that, at least for this particular astrocyte subtype, Olig2 does not behave as a repressor of astrocytogenesis. Nonetheless, this observation raises the question whether expression of Olig2 confers specific functional properties to these astrocytes. During the past decade, evidence has accumulated that astrocytes represent remarkably heterogeneous cells that differ in their morphology, developmental origin, gene expression profile, physiological properties, function, and response to injury and disease (Adams & Gallo, 2018; Ben Haim & Rowitch, 2017) . Our study, by revealing the time of birth and molecular identity of pMN-derived astrocytes as well as a key regulator of their production during development, therefore represents an important advance in clarifying astrocyte heterogeneity in the spinal cord.
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